DuPont’s Microbiome Venture announces second strategic partnership
Three months after its formation, the DuPont Nutrition & Health Microbiome Venture has announced its second strategic research and development partnership.
Three months after its formation, the DuPont Nutrition & Health Microbiome Venture has announced its second strategic research and development partnership. The newly forged relationship with the Center of Food and Fermentation Technologies (TFTAK) in Tallinn, Estonia, will focus on developing cultivation and bioprocess capabilities for “next-generation” probiotics.
The term “next generation,” as defined in this partnership, refers to commensal microbes naturally resident in the gastrointestinal tract and demonstrated to be associated with health and wellness. Such microbes typically have fastidious growth requirements, which must be mastered in order to be able to produce them at scale.
“We are delighted to be partnering with TFTAK,” said Sebastien Guery, Microbiome Venture leader. “With its excellent capabilities in bioprocess technology and systems biology, TFTAK will support DuPont by defining the optimum conditions required to culture and produce some of our next-generation probiotic strain candidates.”